Company intelligence / Profile preview

InSource Diagnostics

Monrovia, California, United Statesfacebook.com ↗

Ownership: Private
Development stage: Other

Overview

InSource Diagnostics operates as a CLIA-certified clinical diagnostic laboratory, offering a broad menu of tests including therapeutic drug monitoring and drugs-of-abuse screening. The company is running the SPHERE Registry clinical trial to validate urine biomarkers that predict genetic mutations affecting drug metabolism, particularly for opioids, benzodiazepines, tricyclic antidepressants, and muscle relaxants. The lab uses advanced technologies such as LC/MS/MS and high-complexity immunoassays in its operations.

Therapeutic areas: PsychiatryNeurologyMetabolic Disorders
Modalities: Diagnostic testingGenetic testingTherapeutic drug monitoring
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on InSource Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on InSource Diagnostics.

Explore the full profile